The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells

Glioblastoma (GBM) is the most aggressive primary brain tumor in adults. Despite progress in surgical and medical neuro-oncology, prognosis for GBM patients remains dismal, with a median survival of only 14–15 months. The modest benefit of conventional therapies is due to the presence of GBM stem ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Affinito, Alessandra, Quintavalle, Cristina, Esposito, Carla Lucia, Roscigno, Giuseppina, Vilardo, Claudia, Nuzzo, Silvia, Ricci-Vitiani, Lucia, De Luca, Gabriele, Pallini, Roberto, Kichkailo, Anna S., Lapin, Ivan N., de Franciscis, Vittorio, Condorelli, Gerolama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796606/
https://www.ncbi.nlm.nih.gov/pubmed/31541799
http://dx.doi.org/10.1016/j.omtn.2019.08.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796606/
https://www.ncbi.nlm.nih.gov/pubmed/31541799
http://dx.doi.org/10.1016/j.omtn.2019.08.015

Ejemplares similares